SCHEMBL6276756

SCHEMBL6276756

CCOc1c(O)c2cccc(OCC(O)CO)c2oc1=O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ AGTR1 P30556 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ ADORA3 P0DMS8 3/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ ADORA1 P30542 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.38
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6274542 0.90 CYP1A2 (0.43) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL6271376 0.89 ADORA3 (0.38) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL6276266 0.88 CYP1A2 (0.42) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL6276710 0.88 CYP1A2 (0.42) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL6274275 0.88 CYP1A2 (0.42) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL6277965 0.86 CYP1A2 (0.42) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL6277966 0.85 CYP1A2 (0.41) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL6274704 0.83 ADORA3 (0.45) KDM4EADORA3ADORA2AADORA1ALDH1A1
SCHEMBL6274560 0.83 GPR35 (0.45) CYP1A2KDM4EMEN1CYP2C19KMT2A
SCHEMBL6276134 0.82 ADORA3 (0.42) KDM4EADORA3ADORA2AADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
CN-1473565-A Benzopyrany/derivatives and antiallergic agent ���ձ���ī��ѧ��ʽ���� 2004-02-11 — — CN disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 CYP1A2 41/4885KDM4E 965/4885MEN1 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback